Insights into KIF11 pathogenesis in microcephaly-lymphedema-chorioretinopathy syndrome from a lymphatic perspective.

Saved in:
Bibliographic Details
Title: Insights into KIF11 pathogenesis in microcephaly-lymphedema-chorioretinopathy syndrome from a lymphatic perspective.
Authors: Ogmen K; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom., Dobbins SE; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom., Behncke RY; Research Group Lymphovascular Medicine and Translational 3D-Histopathology, Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany., Martinez-Corral I; Department of Immunology, Genetics and Pathology, Uppsala University, Sweden., Brown RC; Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Meier M; Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology and Department of Anatomy and Physiology, University of Melbourne, Victoria, Australia.; Bioinformatics Core Facility, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Ulferts S; Research Group Lymphovascular Medicine and Translational 3D-Histopathology, Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany., Hansmeier NR; Research Group Lymphovascular Medicine and Translational 3D-Histopathology, Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany.; Research Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany., Sackey E; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.; South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, United Kingdom., Alqahtani A; Bioscience Institute, Wolfson Childhood Cancer Research Centre, Brewery Lane, Newcastle University, Newcastle upon Tyne, United Kingdom., Karapouliou C; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom., Grigoriadis D; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom., Del Rey Jimenez JC; South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, United Kingdom., Oberlin M; Földiklinik GmbH & Co. KG, European Center for Lymphology Black Forest, Hinterzarten, Germany., Williams D; The National Congenital Anomaly and Rare Diseases Registration Services (NCARDRS) NHS England, Birmingham Government Hub, Birmingham, United Kingdom., Ekici A; University of Health Sciences, Bursa Yüksek Īhtisas Training and Research Hospital, Department of Pediatric Neurology, Bursa, Turkey., Karaer K; Department of Medical Genetics, Pamukkale University Faculty of Medicine, Denizli, Turkey., Jeffery S; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom., Mortimer P; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.; Dermatology & Lymphovascular Medicine, St George's University Hospitals NHS Foundation Trust, London, United Kingdom., Gordon K; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.; Dermatology & Lymphovascular Medicine, St George's University Hospitals NHS Foundation Trust, London, United Kingdom., Okuda KS; Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology and Department of Anatomy and Physiology, University of Melbourne, Victoria, Australia., Hogan BM; Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology and Department of Anatomy and Physiology, University of Melbourne, Victoria, Australia., Mäkinen T; Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.; Translational Cancer Medicine Program and Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.; Wihuri Research Institute, Helsinki, Finland., Hägerling R; Research Group Lymphovascular Medicine and Translational 3D-Histopathology, Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany.; Research Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany., Mansour S; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.; South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, United Kingdom., Martin-Almedina S; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom., Ostergaard P; School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.
Source: JCI insight [JCI Insight] 2025 Dec 18; Vol. 11 (3). Date of Electronic Publication: 2025 Dec 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: eCollection Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first